4//SEC Filing
Funck, Jr. Robert E. 4
Accession 0001415889-24-005092
CIK 0000001800other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:29 PM ET
Size
11.0 KB
Accession
0001415889-24-005092
Insider Transaction Report
Form 4
Funck Robert E
Vice President, Controller
Transactions
- Award
Option (right to buy)
2024-02-21+92,137→ 92,137 totalExercise: $116.98From: 2025-02-21Exp: 2034-02-20→ Common Shares (92,137 underlying) - Award
Common shares without par value
2024-02-21+24,519→ 222,756 total
Holdings
- 20,000(indirect: By Trust)
Common shares without par value
- 500(indirect: By Daughter)
Common shares without par value
- 20,000(indirect: By Trust)
Common shares without par value
- 18,765(indirect: By Trust)
Common shares without par value
Footnotes (5)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
- [F3]Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2024.
- [F4]The reporting person disclaims beneficial ownership of all securities held by his daughter.
- [F5]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,712 on February 21, 2025, 30,712 on February 21, 2026, and 30,713 on February 21, 2027.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001565892
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:29 PM ET
- Size
- 11.0 KB